Fig. 3From: The role of chemotherapy in patients with stage IB gastric adenocarcinoma: a real-world competing risk analysisSurvival curves of the stage IB GAC patients for the chemotherapy and no-chemotherapy cohorts in different subgroups before PSM. OS (A) and CSS (G) in the T1 cohort. OS (B) and CSS (H) in the T2a cohort. OS (C) and CSS (I) in the RNE1-15 cohort. OS (D) and CSS (J) in RNE>16 cohort. OS (E) and CSS (K) in without radiation cohort. OS (F) and CSS (L) in with radiation cohortBack to article page